D. Papanti
发表
M. A. De Luca,
G. Di Chiara,
L. Orsolini,
2017,
CNS & neurological disorders drug targets.
L. Orsolini,
F. Schifano,
D. McQueen,
2017,
Current neuropharmacology.
L. Orsolini,
F. Schifano,
J. Corkery,
2016,
Current topics in behavioral neurosciences.
L. Orsolini,
F. Schifano,
A. Guirguis,
2019,
Expert review of neurotherapeutics.
A. Ventura,
S. Naviglio,
V. Moressa,
2015,
BMJ : British Medical Journal.
L. Orsolini,
F. Schifano,
D. de Berardis,
2018,
Front. Psychiatry.
L. Orsolini,
F. Schifano,
D. Papanti,
2014
.
U. Volpe,
C. Tomasetti,
F. Vellante,
2020,
Human psychopharmacology.
Laura Orsolini,
Fabrizio Schifano,
John Corkery,
2017,
Human psychopharmacology.
L. Orsolini,
F. Schifano,
J. Corkery,
2017,
Human psychopharmacology.
L. Orsolini,
F. Schifano,
D. Papanti,
2015,
Human psychopharmacology.
L. Orsolini,
F. Schifano,
A. Guirguis,
2018
.
L. Orsolini,
F. Schifano,
J. Corkery,
2019,
Journal of psychopharmacology.
L. Orsolini,
F. Schifano,
D. de Berardis,
2019,
Front. Psychiatry.
L. Orsolini,
F. Schifano,
A. Guirguis,
2019
.
G. Martinotti,
R. Santacroce,
O. Corazza,
2017,
CNS & neurological disorders drug targets.
L. Orsolini,
F. Schifano,
D. de Berardis,
2020,
Current neuropharmacology.
L. Orsolini,
F. Schifano,
J. Corkery,
2015,
Human psychopharmacology.
G. Martinotti,
M. Di Giannantonio,
E. Cinosi,
2017,
Human psychopharmacology.
F. Schifano,
D. Papanti,
Tommaso Bonavigo,
2013,
Human psychopharmacology.
A. Valchera,
F. Schifano,
D. Papanti,
2016,
European Psychiatry.
A. Cipriani,
C. Barbui,
F. Gardellin,
2014,
BMC Research Notes.
L. Orsolini,
F. Schifano,
J. Corkery,
2017,
Human psychopharmacology.
G. Di Iorio,
G. Carrà,
A. Atti,
2016,
The International journal of social psychiatry.
D. Krupchanka,
J. Klimas,
D. Papanti,
2019,
BJPsych International.
G. Martinotti,
S. Sensi,
F. Schifano,
2023,
Pharmaceuticals.
L. Orsolini,
F. Schifano,
J. Corkery,
2016,
Expert review of clinical pharmacology.
A. Cipriani,
C. Barbui,
F. Gardellin,
2013,
BMC Psychiatry.
M. A. De Luca,
G. Di Chiara,
L. Orsolini,
2017,
CNS & neurological disorders drug targets.